ULCC vs VRTX · rev $3.72B vs P/E 30, rev $12.00B
Frontier Group Holdings Inc (ULCC) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Frontier Group Holdings Inc (ULCC) is a airlines company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ULCC revenue for 2025-12-31 was $3.72B. Net income was -$137.0M. Revenue was down 1.4% from 2024-12-31 to 2025-12-31. ULCC currently screens at market cap $1.53B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ULCC currently screens at market cap $1.53B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ULCC and VRTX stock pages for the full models.
Not investment advice.